| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |